McKesson Co. (NYSE:MCK) Shares Acquired by Great Waters Wealth Management

Great Waters Wealth Management grew its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 188.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,871 shares of the company's stock after buying an additional 1,877 shares during the period. Great Waters Wealth Management's holdings in McKesson were worth $1,636,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in MCK. Thrivent Financial for Lutherans grew its position in McKesson by 5.5% in the second quarter. Thrivent Financial for Lutherans now owns 19,036 shares of the company's stock worth $11,117,000 after buying an additional 998 shares during the last quarter. Westwood Holdings Group Inc. bought a new position in shares of McKesson during the 2nd quarter valued at $2,596,000. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of McKesson by 21.1% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 13,545 shares of the company's stock worth $7,911,000 after acquiring an additional 2,363 shares in the last quarter. Kowal Investment Group LLC raised its position in shares of McKesson by 6.5% in the second quarter. Kowal Investment Group LLC now owns 474 shares of the company's stock valued at $277,000 after purchasing an additional 29 shares during the period. Finally, Frank Rimerman Advisors LLC boosted its holdings in McKesson by 14,900.0% during the second quarter. Frank Rimerman Advisors LLC now owns 900 shares of the company's stock valued at $526,000 after acquiring an additional 894 shares during the period. Institutional investors and hedge funds own 85.07% of the company's stock.

Analysts Set New Price Targets

Several analysts have issued reports on MCK shares. Bank of America decreased their price target on shares of McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. StockNews.com upgraded shares of McKesson from a "hold" rating to a "buy" rating in a research report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of McKesson from $623.00 to $579.00 and set a "buy" rating on the stock in a research note on Wednesday, September 25th. Mizuho started coverage on McKesson in a research note on Wednesday, December 4th. They set a "neutral" rating and a $630.00 price objective for the company. Finally, Baird R W upgraded McKesson from a "hold" rating to a "strong-buy" rating in a research report on Thursday, November 7th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, McKesson presently has a consensus rating of "Moderate Buy" and an average price target of $646.14.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 579 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total value of $331,645.41. Following the transaction, the executive vice president now owns 864 shares in the company, valued at $494,890.56. This trade represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.11% of the stock is currently owned by insiders.

McKesson Stock Down 1.2 %

Shares of NYSE MCK traded down $7.06 during trading on Tuesday, reaching $585.51. The company had a trading volume of 981,204 shares, compared to its average volume of 676,027. The business's 50-day moving average is $594.65 and its 200 day moving average is $561.08. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The stock has a market cap of $74.32 billion, a PE ratio of 30.32, a P/E/G ratio of 1.28 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, topping the consensus estimate of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business had revenue of $93.65 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same period last year, the firm earned $6.23 earnings per share. The company's quarterly revenue was up 21.3% on a year-over-year basis. On average, analysts anticipate that McKesson Co. will post 32.73 earnings per share for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were paid a $0.71 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 annualized dividend and a yield of 0.49%. McKesson's dividend payout ratio (DPR) is currently 14.71%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.